2024 Global Crohn's Disease Treatment Market Size, Share, Trends And Growth Analysis Report | AbbVie Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Celgene Corporation, Eli Lilly and Company

"The new report published by The Business Research Company, titled ""Crohn's Disease Treatment Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=10852&type=smp

Rising Tide Of Inflammatory Bowel Disorders Drives Crohn'S Disease Treatment Market
The increase in the prevalence of inflammatory bowel disorders is expected to propel the growth of the Crohn's disease treatment market going forward. Inflammatory bowel disorders refer to a group of chronic conditions involving gastrointestinal tract inflammation. It can cause inflammation and damage to any part of the digestive system, from the mouth to the anus. Crohn's disease helps by decreasing the inflammation of the intestine, to prevent flare-ups of symptoms, and to keep in remission. For instance, in April 2020, according to a survey by the American Gastroenterological Association covering 33 countries on six continents regarding the prevalence of and factors associated with functional gastrointestinal disorders, among the 73,076 adult respondents, more than 40% of persons worldwide have Functional gastrointestinal disorders (FGIDs), which affect the quality of life and health care use. Therefore, the increase in the prevalence of inflammatory bowel disorders is driving the growth of the Crohn's disease treatment market.

Product Innovation Propels Crohn's Disease Treatment To New Heights
Product innovation is the key trend gaining popularity in the Crohn's disease treatment market. Major companies operating in the Crohn's disease treatment sector are focused on developing innovative products to strengthen their position in the market. For instance, in May 2023, AbbVie Inc., a US-based pharmaceutical company, received Rinvoq (upadacitinib) approval from U.S. Food and Drug Administration (FDA). Rinvoq is indicated for treating moderate to highly active Crohn's disease. Rinvoq's efficacy and safety were assessed in two randomized induction studies, CD-1 (NCT03345836) and CD-2 (NCT03345849), involving 857 patients with moderately to highly active Crohn's disease.

The crohn's disease treatment market covered in this report is segmented -

1) By Drug Type: Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine Post-Operative Pain, Cancer Pain, Other Applications

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=10852&type=discount

Major companies operating in the crohn's disease treatment market report are AbbVie Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Celgene Corporation, Eli Lilly and Company, Janssen Pharmaceuticals, Pfizer Inc., Takeda Pharmaceutical Company Limited, Biogen Inc., Bristol-Myers Squibb Company, Galapagos NV, Gilead Sciences Inc., Novartis AG, Sanofi S.A., Union Chimique Belge, Astellas Pharma Inc., F. Hoffmann-La Roche Ltd., Vertex Pharmaceuticals Incorporated, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Regeneron Pharmaceuticals Inc., Mylan N.V., Glenmark Pharmaceuticals, Tillotts Pharma AG, Dr. Falk Pharma GmbH, Shire Pharmaceuticals, Salix Pharmaceuticals, Prometheus Laboratories Inc., Arena Pharmaceuticals Inc.

Contents of the report:
1. Executive Summary
2. Crohn's Disease Treatment Market Report Structure
3. Crohn's Disease Treatment Market Trends And Strategies
4. Crohn's Disease Treatment Market - Macro Economic Scenario
5. Crohn's Disease Treatment Market Size And Growth
…..
27. Crohn's Disease Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.